Unmodified or poorly glycosylated proteins fail the ER quality control check, remain bound to chaperones, and are targeted for ER-associated degradation (ERAD).
Unmodified or poorly glycosylated proteins fail the ER quality control check, remain bound to chaperones, and are targeted for ER-associated degradation (ERAD).